This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

UBS Remains a Hold on Healthpeak Properties (DOC)

Tipranks - Tipranks - Thu May 14, 6:36AM CDT

UBS analyst Michael Goldsmith maintained a Hold rating on Healthpeak Properties today and set a price target of $19.00.

Claim 55% Off TipRanks

According to TipRanks, Goldsmith is a 4-star analyst with an average return of 5.2% and a 62.26% success rate. Goldsmith covers the Real Estate sector, focusing on stocks such as Healthpeak Properties, W. P. Carey Inc., and Sabra Healthcare REIT.

In addition to UBS, Healthpeak Properties also received a Hold from Citi’s Nicholas Joseph in a report issued yesterday. However, on May 6, Morgan Stanley maintained a Buy rating on Healthpeak Properties (NYSE: DOC).

See the top stocks recommended by analysts >>

Based on Healthpeak Properties’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $752.95 million and a net profit of $193.63 million. In comparison, last year the company earned a revenue of $702.89 million and had a net profit of $42.83 million

Read More on DOC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).